v3 Template
E

Eyconis, Inc.

Biotechnology / Healthcare ~320 employees
Founded
--
Employees (Est.)
~320
16 leaders known
Total Funding
$150.0M
Funding Rounds
1
Last Funding
2024-01-29

About Eyconis, Inc.

Eyconis is a biotechnology company focused on developing novel therapies to transform the lives of patients with eye diseases. The company aims to address high unmet needs in ophthalmology, particularly for conditions like wet age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and geographic atrophy (GA), by delivering long-acting and effective treatments using clinically validated and emerging medicines.

Products & Services

Ophthalmology Therapeutics:Developing long-acting delivery systems for therapies targeting major causes of blindness, including wet AMD, DME, RVO, and GA.

Specialties

Ophthalmology Long-acting drug delivery Therapies for eye diseases Wet age-related macular degeneration (AMD) Diabetic macular edema (DME) Retinal vein occlusion (RVO) Geographic atrophy (GA)

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Initial Capital Commitment
T: -
FT: Initial Capital Commitment 		A: 150000000
MR: -
FA: $150 Million
FAN: 150000000 		D: 2024-01-29
FD: 2024-01-29 		4 investors
Initial Capital Commitment Latest
2024-01-29
$150.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Mark Bachleda

Chief Executive Officer

LinkedIn (Pro only)
E

Emmett T. Cunningham, Jr.

Co-Founder & Executive Chairman of the Board

LinkedIn (Pro only)
R

Robert L. Vitti

Chief Medical Officer

LinkedIn (Pro only)
O

Oliver Stauch

Chief Operating Officer

K

Karen Chu

Senior Vice President, Clinical Development and Operations

Y

YongQi Mu

Vice President, Development Chemistry

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

Eyconis, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~320 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro